Cansino Biologics Inc (688185) — Cash Flow Reinvestment Rate
Cansino Biologics Inc (688185) has a Cash Flow Reinvestment Rate of 1.45x as of September 2025, reinvesting CN¥44.23 Million (capex CN¥44.23 Million ) from operating cash flow of CN¥30.53 Million. See 688185 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cansino Biologics Inc Cash Flow Reinvestment Rate (2021–2025)
Historical reinvestment intensity for Cansino Biologics Inc across 2 annual periods. For the full cash flow conversion analysis, see Cansino Biologics Inc cash conversion from operations.
Annual Cash Flow Reinvestment Rate for Cansino Biologics Inc (2021–2025)
Year-by-year capital reinvestment analysis for Cansino Biologics Inc. See how financially flexible is Cansino Biologics Inc to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 10.78x | CN¥839.60 Million | CN¥77.86 Million | CN¥243.90 Million | ▲ +733.6% |
| 2021 | 1.29x | CN¥2.61 Billion | CN¥2.01 Billion | CN¥1.20 Billion | — |